UPDF AI

A bibliometric analysis of the current research status and hotspots regarding Aducanumab treatment for Alzheimer's disease

Dingwen Xu,Jijun Wu,3 Authors,Zhe Yang

2025 · DOI: 10.1007/s00210-025-04448-6
Naunyn-Schmiedeberg's Archives of Pharmacology · 0 Citations

TLDR

Bibliometric methods are employed to reveal the publication trends related to Aducanumab in the context of Alzheimer’s disease, examining collaborations among countries, regions, and authors, as well as recent research hotspots.